Amit Garg

  I have been in Silicon Valley for 20 years -- at Samsung NEXT Ventures, running my own startup (as of May 2019 a series D that has raised $120M and valued at $450M), at Norwest Ventures, and doing product and analytics at Google. My academic training is BS in computer science and MS in biomedical informatics, both from Stanford, and MBA from Harvard. I speak natively 3 languages, live carbon-neutral, am a 70.3 Ironman finisher, and have built a hospital in rural India serving 100,000 people.

 



174 Stories by Amit Garg

Why We Invested In Siftwell — Health Analytics

Excited to announce our investment in the $5.8M seed for Siftwell, a health analytics company that provides reports and insights to payors around their...
1 min read 116

50 States Of Grey: 3 Key Questions For Healthcare Startups As They Navigate The United States (which is not so united in terms of policy)

At Tau Ventures we hear from many entrepreneurs around the world that they want to build or expand a healthcare business into the US...
2 min read 155

2023 Was Very Tough For Startups And Investors, Why And Where Do We Go From Here?

Different parts of the world have fared very differently but sitting in Silicon Valley, overall 2023 has been a difficult year for both startups...
2 min read 229

How To Get Capital From Those Pesky VCs?

Okay, so “pesky” was perhaps clickbait with some truth to it, but it’s undeniable that the fundraising process is inefficient. Some entrepreneurs seem to...
2 min read 126

Healthcare AI — Where Are We?

We started Tau Ventures in 2019 with the fundamental premise that the inflection point of AI was near. Specifically our thesis was predicated on the quadrant...
3 min read

Looking To Raise Venture Capital? 5 Principles To Help Entrepreneurs Navigate The Big Picture

Principle 1: Why Bother With Venture Capital? Of the top 10 companies by market cap, 8 were funded by venture capital (and they all...
2 min read 121

Why We Invested In Transcera — Ceramide Therapeutic Platform

Excited to announce our investment in the seed for Transcera, a biotech company developing a ceramide lipid-based drug delivery platform that utilizes active transport pathways to increase...
1 min read 342

Radiology AI — Where Are We?

We started Tau in 2019 with the fundamental premise that the inflection point of AI was near. Specifically our thesis was predicated on the...
2 min read 223

Why We Invested In Blueprint - Better Mental Health

Excited to announce our investment in the $9M series A for Blueprint Health, which helps mental health providers deliver effective treatment, more here. The...
1 min read 178

Shares In My Own Startup? How To Think Through Equity

How to divide equity among cofounders and employees is a perennial question in startup world. This article builds on Startup101: How Do I Divide Equity...
2 min read 283

Why We Invested In Sami Saúde — Better Healthcare Insurance

Excited to announce investment in the $18M series B of Sami Saúde alongside Redpoint eVentures, Monashees and Valor. Sami is focused on providing better healthcare insurance, starting with...
2 min read 296

Why We Invested In Somethings - Mentorship For Teens

Excited to announce our investment in a $3.2M seed for Somethings, which provides mental health mentorship for teens. We are joined by General Catalyst,...
1 min read 345